...
首页> 外文期刊>Structural Chemistry >Synthesis, FT-Raman, FT-IR, NMR spectroscopic characterization and antimicrobial activity of new mixed aza-oxo-thia macrocyclic compounds
【24h】

Synthesis, FT-Raman, FT-IR, NMR spectroscopic characterization and antimicrobial activity of new mixed aza-oxo-thia macrocyclic compounds

机译:新型氮杂-氧-硫杂大环化合物的合成,FT-Raman,FT-IR,NMR光谱表征和抑菌活性

获取原文
获取原文并翻译 | 示例
           

摘要

Series of new mixed aza-oxo-thia macrocyclic ligands {2,6,12,16-tetraaza-1,7,11,17-tetraoxo-9,19-dithia-[(4′-methyl-5′,4,3′)(14′-methyl-15′,14,13′)]ditriazine}cyclocosane (L 1 ); {2,6,13,17-teraaza-1,7,12,18-tetraoxo-9,10,20,21-tetrathia-[(4′-methyl-5′,4,3′)(15′-methyl-14′,16′,15)]di-triazine}cyclodocosane (L 2 ); {2,6,14,18-tetraaza-1,7,13,19-tetraoxo-10,22-dithia-[(4′-methyl-5′,3′,4)(16′-methyl-15′,17′,16)]ditriazine}cyclotetracosane (L 3 ) and {2,6,15,19-tetraaza-1,7,14,12-tetraoxo-10,11,23,24-tetrathia-[(4′-methyl-5′,4,3′)(17′-methyl-8′,17,16′)]ditriazine}cyclohexa-cosane (L 4 ) were synthesized. The structural features of the compounds have been studied by elemental analyses, Mass, FT-Raman, FT-IR, 1H and 13C NMR spectroscopy. The antimicrobial activities of the ligands were evaluated using disk diffusion method in dimethyl sulfoxide as well as the minimal inhibitory concentration (MIC) dilution method, against 9 bacteria. The obtained results from disk diffusion method were assessed in side-by-side comparison with those of Penicillin-g, Ampicillin, Cefotaxime, Vancomycin, Oflaxacin, and Tetracyclin, well-known antibacterial agents. The results from dilution procedure were compared with Gentamycin as antibacterial and Nystatin as antifungal. The antifungal activities are reported on five yeast cultures namely Candida albicans, Kluyveromyces fragilis, Rhodotorula rubra, Debaryomyces hansenii, and Hanseniaspora guilliermondii, and the results are referenced with Nystatin, Ketaconazole, and Clotrimazole, commercial antifungal agents. In most cases, the compounds show strong antifungal activity in the comparison tests.
机译:系列新的混合氮杂-氧-硫杂大环配体{2,6,12,16-四氮杂1,7,11,17-四氧-9,19-二硫杂-[(4'-甲基-5',4, 3′)(14′-甲基-15′,14,13′)]二三嗪}环二十烷(L 1 ); {2,6,13,17-teraaza-1,7,12,18-tetraoxo-9,10,20,21-tetrathia-[(4'-methyl-5',4,3')(15'-甲基-14',16',15)]二-三嗪}环二十烷(L 2 ); {2,6,14,18-tetraaza-1,7,13,19-tetraoxo-10,22-dithia-[(4'-methyl-5',3',4)(16'-methyl-15' ,17',16)] ditriazine} cyclotetracosane(L 3 )和{2,6,15,19-tetraaza-1,7,14,12-tetraoxo-10,11,23,24-tetrathia-合成了[(4'-甲基-5',4,3')(17'-甲基-8',17,16')]二三嗪}环六-二十烷(L 4 )。通过元素分析,质谱,FT-拉曼光谱,FT-IR,1 H和13 C NMR光谱研究了该化合物的结构特征。使用圆盘扩散法在二甲基亚砜中以及最小抑制浓度(MIC)稀释法对9种细菌进行评估,评估了配体的抗菌活性。通过圆盘扩散法获得的结果与著名的抗菌剂青霉素-g,氨苄青霉素,头孢噻肟,万古霉素,氧氟沙星和四环素进行了并排比较。将稀释程序的结果与庆大霉素作为抗菌剂和制霉菌素作为抗真菌剂进行了比较。在五种酵母培养物中报告了其抗真菌活性,分别是白色念珠菌,脆弱克鲁维酵母,红红假单胞菌,汉逊德巴利酵母和汉斯尼氏菌guilliermondii,该结果与制霉菌素,Ketaconazole和Clotrimazole(商业抗真菌剂)有关。在大多数情况下,这些化合物在对比试验中显示出很强的抗真菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号